RuxolitinibLack of efficacy following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2039卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72939-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：502 / 502

相关论文

共 50 条

[1] Bevacizumab/dexamethasone/ruxolitinibLack of efficacy and off-label use: 6 case reports
Reactions Weekly, 2024, 2039 (1) : 105 - 105
[2] VenetoclaxLack of efficacy following off-label use: case report
Reactions Weekly, 2025, 2041 (1) : 398 - 398
[3] DexamethasoneLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1887 (1) : 259 - 259
[4] EculizumabLack of efficacy following off-label use: case report
Reactions Weekly, 2021, 1862 (1) : 196 - 196
[5] DexamethasoneLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1967 (1) : 143 - 143
[6] AntibacterialsLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1920 (1) : 43 - 43
[7] RituximabLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1905 (1) : 444 - 444
[8] FavipiravirLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1945 (1) : 254 - 254
[9] AmiodaroneLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1969 (1) : 29 - 29
[10] VenetoclaxLack of efficacy following off-label use: case report
Reactions Weekly, 2024, 2039 (1) : 550 - 550

← 1 2 3 4 5 →